Bionnovation is entering the U.S. market with a comprehensive portfolio of biomaterials for regenerative dentistry.

PRINCETON, NJ, UNITED STATES, August 13, 2026 /EINPresswire.com/ -- Bionnovation is entering the U.S. market with a comprehensive portfolio of biomaterials for regenerative dentistry. With Bionnovation Allo, Bionnovation Oss XB, and Bionnovation Gide XP, the brand is making quality biomaterials affordable for patients in the U.S. The solutions simplify surgical workflows and standardize treatments for the benefit of both patients and clinicians without compromising in quality.

Bionnovation stands for "Regeneration made easy" and pursues the goal of providing accessible biomaterials for smarter regenerative care. As a brand of the Geistlich Group, Bionnovation combines more than three decades of experience in the development and production of biomaterials for regenerative dentistry with a clear focus on ease of use, reliable outcomes, and economic efficiency.

With the US launch of Bionnovation Allo, Bionnovation Oss XB, and Bionnovation Gide XP, Bionnovation addresses the needs of practices looking for smart, accessible solutions without compromising on quality and safety. These biomaterials are designed to simplify regenerative treatments in everyday dentistry and support standardized workflows.

Bionnovation Allo is a human allograft implant line for repairing, replacing, and reconstructing bone in daily dental procedures. Available in multiple graft types and volume options, each implant is processed using the Cancelle SP^® Sterilization Process to ensure sterility.1

Bionnovation Oss XB is a xenograft that preserves natural bone structure, porosity, and topography through a patented purification process, providing a biomimetic, regulatory-certified alternative to conventional xenografts. Available in small granules and multiple fill quantities, the material supports efficient clinical workflows and reliable regenerative performance.

Bionnovation Gide XP combines a thin, flexible design with trusted Geistlich technology and quality to support daily regenerative procedures, simplifying clinical workflows and making patient treatment easier.

“With Bionnovation, we are bringing solutions to the US market to make everyday regeneration easy”, says William Weber, Global Director of Business Development. “The new line helps dentists to integrate regenerative procedures efficiently and reliably into their daily practice.”

Entering the USA market is an important step in Bionnovation's international development. The Bionnovation line has been positioned for quality-oriented market segments and is intended to appeal to general practitioners looking for accessible and economically balanced regenerative solutions.
About Bionnovation - A Geistlich Group Brand

Founded in 1993 in Brazil, Bionnovation brings more than three decades of expertise in the development and manufacturing of biomaterials for regenerative dentistry. What began as a strong local MedTech company has grown into a fast-expanding brand with solutions established in more than 20 countries. Today, as part of the Geistlich Group, a global leader in oral regeneration with 175 years of pioneering history, Bionnovation stands for quality biomaterials accessible to clinicians and patients worldwide.

The portfolio includes Bionnovation Allo, a human-derived allograft bone substitute; Bionnovation Oss XB, a ready-to-use xenograft bone substitute; and Bionnovation Gide XP, a thin, flexible collagen membrane, each designed to integrate into existing general practice workflows without specialist-level setup. Bionnovation is available directly through the Bionnovation eShop.

References:
1. Cancelle SP^® is a registered trademark of RTI Surgical, Inc. d/b/a Evergen

Steven DiOrio
Bionnovation
+1 855-336-3735
email us here
Visit us on social media:
LinkedIn
Instagram
Facebook
YouTube